Zyprexa Mydapt Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 16 years ago on Thursday, October 11, 2007, according to the United State Patent & Trademark Office
Word Mark Zyprexa Mydapt
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company
Other Trademarks for Eli Lilly and Company
Serial Number 78771510
Status Date Thursday, October 11, 2007
Filing Date Thursday, October 11, 2007
Attorney Robert E. Lee, Jr.

Correspondent

ROBERT E. LEE, JR.
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285-0001

Case File Statements

Goods & Services Pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, December 16, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.